RIPK3 and esophageal cancer: These findings provide new insight into the molecular mechanisms underlying cisplatin-induced necroptosis, and suggest that RIPK3 is a potential marker of cisplatin sensitivity in apoptosis-resistant and advanced esophageal cancer.